| Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey L Longworth, Y Yang, T Young, B Mulhern, M Hernández Alava, ... Health Technology Assessment, 2014 | 374 | 2014 |
| Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values MH Alava, AJ Wailoo, R Ara Value in Health 15 (3), 550-561, 2012 | 181 | 2012 |
| Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report AJ Wailoo, M Hernandez-Alava, A Manca, A Mejia, J Ray, B Crawford, ... Value in Health 20 (1), 18-27, 2017 | 177 | 2017 |
| Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis M Stevenson, T Gomersall, ML Jones, A Rawdin, M Hernández, S Dias, ... Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the …, 2014 | 158 | 2014 |
| Corrigendum: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with … M Stevenson, R Archer, J Tosh, E Simpson, E Everson-Hock, J Stevens, ... Health technology assessment (Winchester, England) 20 (35), 611, 2016 | 151* | 2016 |
| Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease … M Stevenson, R Archer, J Tosh, E Simpson, E Everson-Hock, J Stevens, ... Health Technology Assessment 20 (35), 1-610, 2016 | 151 | 2016 |
| The welfare cost of means‐testing: pensioner participation in income support M Hernandez, S Pudney, R Hancock Journal of Applied Econometrics 22 (3), 581-598, 2007 | 95 | 2007 |
| The welfare cost of means-testing: pensioner participation in income support S Pudney, M Hernandez, R Hancock Economics Discussion Papers, Paper 03 2, 2002 | 95* | 2002 |
| What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. R Ara, L Blake, L Gray, M Hernández, M Crowther, A Dunkley, F Warren, ... NIHR Evaluation, Trials and Studies Coordinating Centre (UK), 2012 | 94 | 2012 |
| The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis M Hernández Alava, A Wailoo, F Wolfe, K Michaud Rheumatology 52 (5), 944-950, 2013 | 92 | 2013 |
| NICE DSU technical support document 17: the use of observational data to inform estimates of treatment effectiveness for technology appraisal: methods for comparative … R Faria, M Hernandez Alava, A Manca, AJ Wailoo Sheffield: NICE Decision Support Unit, 2015 | 91 | 2015 |
| Children’s Development and Parental Input: Evidence From the UK Millennium Cohort Study M Hernández-Alava, G Popli Demography 54 (2), 485-511, 2017 | 85 | 2017 |
| A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes M Hernández Alava, A Wailoo, F Wolfe, K Michaud Medical Decision Making 34 (7), 919-930, 2014 | 74 | 2014 |
| Family lifestyle dynamics and childhood obesity: evidence from the millennium cohort study LA Gray, MH Alava, MP Kelly, MJ Campbell BMC public health 18 (1), 1-15, 2018 | 73 | 2018 |
| BETAMIX: a command for fitting mixture regression models for bounded dependent variables using the beta distribution LA Gray, M Hernandez-Alava Stata J, 2018 | 65* | 2018 |
| Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D A Wailoo, M Hernandez Alava, A Escobar Martinez Health and quality of life outcomes 12 (1), 1-6, 2014 | 62 | 2014 |
| The Take‐Up of Multiple Means‐Tested Benefits by British Pensioners: Evidence from the Family Resources Survey R Hancock, S Pudney, G Barker, M Hernandez, H Sutherland Fiscal studies 25 (3), 279-303, 2004 | 58 | 2004 |
| Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis M Hernández-Alava, S Pudney Journal of Health Economics 55, 139-152, 2017 | 56 | 2017 |
| Measurement error in models of welfare participation M Hernandez, S Pudney Journal of Public Economics 91 (1), 327-341, 2007 | 55 | 2007 |
| Health state preference weights for the Glasgow Outcome Scale following traumatic brain injury: a systematic review and mapping study GW Fuller, M Hernandez, D Pallot, F Lecky, M Stevenson, B Gabbe Value in health 20 (1), 141-151, 2017 | 44 | 2017 |
